Table of contents

Original Articles: PDF Only

• Development and in vitro characterization of a GM-CSF secreting human ovarian carcinoma tumor vaccine

  (1 October, 1995)

  J. K. Lander, A. D. Santin, G. R. Ioli, J. C. Hiserodt, G. S. Rose, M. R. Graf, P. J. Disaia, S. Pecorelli, G. A. Granger
• ErbB-2, a c-erbB-2-coded protein, is expressed in metastatic cells of adenocarcinoma of endometrium, cervix and ovaries (1 October, 1995)

  H. Sakamoto, X. Deng, K. Ohtani, T. Takami, M. Takami, T. Shirakawa, K. Satoh
• Surgery and prognosis in stage III epithelial ovarian cancer (1 October, 1995)

  G. Ing, N. Semrad, S. Jordan, F. Latino, W. G. Watring
• Squamous endometrial neoplasia—are Fluhmann's postulates still relevant? (1 October, 1995)

  J. C. Dalrymple, P. Russell
• The LonStenn—a new cervical sampling device (1 October, 1995)

  H. M. Stenning, D. B.B. Stenning, G. R. Rajasekariah, M. Stadler-Prelec, V. Gebski
• Pure malignant immature teratoma of the ovary: the role of chemotherapy and second-look surgery (1 October, 1995)

  S. Culine, C. Lhomme, J. Kattan, G. Michel, P. Duvillard, J. P. Droz
• Immunocompetent for immunotherapy? A study of the immunocompetence of cervical cancer patients (1 October, 1995)

  A. N. Fiander, M. Adams, A. S. Evans, A. J. Bennett, L. K. Borysiewicz
• Carboplatin and etoposide as first-line chemotherapy in advanced epithelial ovarian cancer (1 October, 1995)

  D. Z. Edelmann, T. Peretz, V. Barak, S. O. Anteby
• Conclusions and recommendations from the Helene Harris Memorial Trust Fifth Biennial International Forum on Ovarian Cancer, May 4–7, 1995, Glasgow, UK (1 October, 1995)

  F. Sharp, A. D. Blackett, R. E. Leake, J. S. Berek